Three leading coronavirus vaccine developers -- Pfizer Inc and AstraZeneca Plc and Bharat Biotech -- have applied for emergency use authorisation in India.
Challenges in cold chain management of the vaccine, which involves maintaining the vaccine at a constant temperature, has been addressed, says Minister
"SII has applied for emergency use authorisation to DCGI. The application will be reviewed by the expert committee and after that final call will be taken," a senior government official confirmed ANI.
Britain on Wednesday gave emergency approval to the Pfizer-BioNTech coronavirus vaccine, with health officials set to use criteria based on age and vulnerability to decide the order of people to receive it.
Delhi airport authorities said that besides the cool chamber, it also has "cool dollies" at the airside that ensure an unbroken cool chain during temperature-sensitive cargo movement between terminal and aircraft.
Poonawalla joined the Serum Institute of India in 2001 and became the CEO of Serum Institute with complete control of the day-to-day operations of the company in 2011.
Overall level of positive sentiment climbed to the highest since February amid predictions that market conditions would normalise once a Covid vaccine is rolled out
Prime Minister Boris Johnson said the move heralded a vaccination programme "that will ultimately allow us to reclaim our lives and get the economy moving again".
He will be proceeding to Bharat Biotech's facility located at Genome valley, a life sciences cluster about 20 km from the Air Force base, officials said.